DEFINITIVE PROXY STATEMENT

Company

Coeptis Therapeutics Holdings, Inc.

Filed

November 19, 2021

Period of Report

December 16, 2021

Accession Number

0001213900-21-060868

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →